Jiayuh Lin Selected Research

1,5- bis(3,5- bis(methoxymethoxy)phenyl)penta- 1,4- dien- 3- one

10/2009	Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
3/2009	New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiayuh Lin Research Topics

Disease

76	Neoplasms (Cancer) 05/2022 - 01/2002
25	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
16	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 07/2009
8	Carcinogenesis 01/2021 - 09/2005
8	Rhabdomyosarcoma 01/2017 - 06/2007
7	Neoplasm Metastasis (Metastasis) 03/2021 - 09/2005
7	Colonic Neoplasms (Colon Cancer) 08/2019 - 12/2011
7	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 08/2010
6	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 04/2004
6	Inflammation (Inflammations) 02/2021 - 08/2010
6	Liver Neoplasms (Liver Cancer) 08/2017 - 08/2010
6	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 06/2007
5	Medulloblastoma 01/2021 - 02/2015
4	Triple Negative Breast Neoplasms 05/2020 - 11/2018
4	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 04/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2012 - 05/2002
3	Colorectal Neoplasms (Colorectal Cancer) 02/2019 - 03/2009
3	Leukemia 01/2012 - 04/2004
3	Glioblastoma (Glioblastoma Multiforme) 09/2010 - 01/2010
2	Atherosclerosis 02/2021 - 11/2020
2	Osteoporosis 02/2021 - 01/2017
2	Abdominal Aortic Aneurysm 01/2020 - 01/2018
2	Multiple Myeloma 01/2017 - 08/2010
2	Stomach Neoplasms (Stomach Cancer) 01/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2012 - 06/2010
1	Atherosclerotic Plaque (Atheroma) 02/2021
1	Heart Failure 01/2021
1	Hypertrophy 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Fibrosis (Cirrhosis) 01/2021

Drug/Important Bio-Agent (IBA)

41	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 01/2002
30	Interleukin-6 (Interleukin 6)IBA 05/2021 - 10/2008
14	bazedoxifeneIBA 05/2022 - 01/2016
14	CurcuminIBA 01/2012 - 02/2009
12	Pharmaceutical PreparationsIBA 01/2019 - 03/2010
11	FLLL 32IBA 03/2016 - 03/2010
10	CytokinesIBA 01/2022 - 06/2010
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2004
9	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 04/2004
9	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 01/2002
8	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 05/2002
7	SurvivinIBA 05/2022 - 09/2005
7	Transcription Factors (Transcription Factor)IBA 03/2021 - 10/2009
6	Phosphotransferases (Kinase)IBA 05/2021 - 04/2004
6	Caspase 3 (Caspase-3)IBA 10/2013 - 03/2009
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 11/2016
5	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2004
4	Raloxifene Hydrochloride (Evista)FDA Link 01/2021 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 09/2005
4	Biological ProductsIBA 02/2018 - 12/2012
4	Aldehyde DehydrogenaseIBA 12/2016 - 12/2011
3	ApolipoproteinsIBA 02/2021 - 01/2018
3	Cyclin D1IBA 01/2021 - 07/2011
3	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2002
3	Glycoproteins (Glycoprotein)IBA 01/2020 - 03/2019
3	Estrogen ReceptorsIBA 06/2019 - 09/2005
3	Gemcitabine FDA Link 01/2019 - 03/2016
3	Ursolic AcidIBA 01/2018 - 10/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 03/2010
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 12/2013
3	AZD 6244IBA 01/2016 - 12/2013
3	STA-21IBA 10/2008 - 03/2005
2	2- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamideIBA 05/2022 - 07/2018
2	ChemokinesIBA 01/2022 - 07/2018
2	Apolipoproteins E (ApoE)IBA 02/2021 - 11/2020
2	PlatinumIBA 01/2021 - 01/2020
2	ElastinIBA 01/2020 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 09/2005
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2019 - 09/2005
2	InterleukinsIBA 03/2019 - 07/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2019 - 01/2019
2	Interleukin-11 (Interleukin 11)IBA 02/2019 - 11/2016
2	Bromodeoxyuridine (BrdU)IBA 02/2019 - 07/2018
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 09/2007
2	Dasatinib (BMS 354825)FDA Link 01/2019 - 01/2019
2	Interleukin-8 (Interleukin 8)IBA 11/2018 - 07/2018
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 12/2013
2	statticIBA 01/2013 - 12/2011
2	Annexin A5IBA 01/2012 - 06/2010
2	Celecoxib (Celebrex)FDA Link 08/2011 - 04/2011
2	AgarIBA 03/2010 - 09/2009
2	1,5- bis(3,5- bis(methoxymethoxy)phenyl)penta- 1,4- dien- 3- oneIBA 10/2009 - 03/2009
2	Janus Kinase 2IBA 08/2004 - 04/2004
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 05/2022
1	AntigensIBA 01/2022
1	LigandsIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2021
1	talazoparibIBA 05/2021
1	Indicators and Reagents (Reagents)IBA 02/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	taxaneIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 10/2020
1	Phenobarbital (Luminal)FDA Link 05/2020

Therapy/Procedure

34	Therapeutics 05/2022 - 03/2002
9	Drug Therapy (Chemotherapy) 01/2021 - 03/2011
3	Chemoprevention 05/2017 - 01/2012
2	Oral Administration 06/2019 - 01/2017
1	Immunotherapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021